Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Aug 24, 2022 | Aug 25, 2022 | Hillan Kenneth J. Chief Therapeutics Officer | Sell | 23Andme Holding Co. | ME | $3.64 | $31,861 | -4.27% |
Jun 26, 2018 | Jun 28, 2018 | Hillan Kenneth J. | Sell | Achaogen Inc | AKAO | $9.59 | $7,135 | -0.64% |
Mar 13, 2018 | Mar 15, 2018 | Hillan Kenneth J. | Sell | Achaogen Inc | AKAO | $11.74 | $32,109 | -2.79% |
Feb 21, 2018 | Feb 24, 2018 | Hillan Kenneth J. | Sell | Achaogen Inc | AKAO | $10.67 | $49,146 | -4.49% |
Mar 14, 2017 | Mar 16, 2017 | Hillan Kenneth J. CEO | Sell | Achaogen Inc | AKAO | $26.58 | $81,840 | -3.03% |
Feb 21, 2017 | Feb 24, 2017 | Hillan Kenneth J. CEO | Sell | Achaogen Inc | AKAO | $22.76 | $38,601 | -2.68% |
Jan 26, 2017 | Jan 31, 2017 | Hillan Kenneth J. CEO | Sell | Achaogen Inc | AKAO | $16.78 | $24,012 | -2.21% |
Jun 07, 2016 | Jun 08, 2016 | Hillan Kenneth J. Dir | Sell | Relypsa Inc | RLYP | $19.31 | $19,563 | -45.02% |
Mar 17, 2016 | Mar 21, 2016 | Hillan Kenneth J. CEO | Sell | Achaogen Inc | AKAO | $3.22 | $11,502 | -5.48% |